Skip to main content

Table 2 Basal echocardiographic characteristics in SGLT2i and control group

From: Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study

Variable

SGLT2i (n = 30)

Control (n = 22)

p value

LV end-diastolic diameter (mm)

46.9 ± 5.0

44.5 ± 4.3

0.08

LV end-diastolic volume (ml)

103.3 ± 40.0

97.0 ± 25.7

0.52

LV indexed end-diastolic volume (ml/m2)

52.6 ± 18.9

50.2 ± 9.7

0.59

LV end-systolic volume (ml)

40.7 ± 26.5

33.9 ± 8.5

0.19

LV ejection fraction (%)

62.9 ± 8.2

64.6 ± 5.8

0.43

LV ejection fraction < 50%

2 (7%)

0 (0%)

0.50

E wave (cm/s)

72.2 ± 25.5

64.2 ± 19.7

0.22

A wave (cm/s)

82.8 ± 18.9

87.5 ± 19.2

0.41

LA indexed volume (ml/m2)

31.9 ± 9.8

28.7 ± 9.1

0.23

Lateral e’ (cm/s)

8.3 ± 2.2

8.3 ± 3.2

0.95

Septal e’ (cm/s)

5.9 ± 1.4

5.8 ± 1.2

0.73

E/A ratio

0.83 ± 0.39

0.81 ± 0.26

0.80

E/e’ ratio

10.5 ± 3.6

9.8 ± 2.4

0.40

LV indexed mass (g/m2)

98.5 ± 27.9

90.8 ± 21.0

0.28

RWT

0.47 ± 0.07

0.49 ± 0.08

0.29

GLS

− 17.8 ± 2.9

− 19.6 ± 2.5

0.02

  1. LV left ventricular, LA left atrial, RWT relative wall thickness, GLS global longitudinal strain